Image of Hematology
Split Viewer
Blood Res 2018; 53(1):
Published online March 31, 2018
https://doi.org/10.5045/br.2018.53.1.9
© The Korean Society of Hematology
Renal cell carcinoma metastasizing to the myeloproliferative bone marrow
1Section of Benign Hematology, The University of Texas M.D. Anderson Cancer Center, Houston, USA.
2Department of Hematopathology, The University of Texas M.D. Anderson Cancer Center, Houston, USA.
Correspondence to : Thein Hlaing Oo, M.D., Section of Benign Hematology, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 1464, Houston, TX 77030, USA. theinoomd@gmail.com, thoo@mdanderson.org
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
PDF
Standard view
Export citation
Share Article
Image of Hematology
Blood Res 2018; 53(1): 9-9
Published online March 31, 2018 https://doi.org/10.5045/br.2018.53.1.9
Copyright © The Korean Society of Hematology.
Renal cell carcinoma metastasizing to the myeloproliferative bone marrow
Thein Hlaing Oo1*, and Roberto Nicolas Miranda2
1Section of Benign Hematology, The University of Texas M.D. Anderson Cancer Center, Houston, USA.
2Department of Hematopathology, The University of Texas M.D. Anderson Cancer Center, Houston, USA.
Correspondence to:Thein Hlaing Oo, M.D., Section of Benign Hematology, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 1464, Houston, TX 77030, USA. theinoomd@gmail.com, thoo@mdanderson.org
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
